Sponsor pipeline

SynOx Therapeutics Limited clinical trial pipeline

Get alerts when SynOx Therapeutics Limited's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05417789 Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) TGCT Active, Not Recruiting 2026-07-29
Get alerts when SynOx Therapeutics Limited's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free